Align Technology Inc (ALGN)vsWest Pharmaceutical Services Inc (WST)
ALGN
Align Technology Inc
$173.66
+2.71%
HEALTHCARE · Cap: $12.11B
WST
West Pharmaceutical Services Inc
$354.07
+1.57%
HEALTHCARE · Cap: $24.00B
Smart Verdict
WallStSmart Research — data-driven comparison
Align Technology Inc generates 24% more annual revenue ($4.14B vs $3.33B). WST leads profitability with a 17.0% profit margin vs 10.0%. ALGN appears more attractively valued with a PEG of 0.80. WST earns a higher WallStSmart Score of 61/100 (C+).
ALGN
Buy56
out of 100
Grade: C
WST
Buy61
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+32.9%
Fair Value
$294.47
Current Price
$173.66
$120.81 discount
Margin of Safety
-47.9%
Fair Value
$166.45
Current Price
$354.07
$187.62 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Growing faster than its price suggests
Reasonable price relative to book value
Safe zone — low bankruptcy risk
Conservative balance sheet, low leverage
Strong operational efficiency at 22.5%
Areas to Watch
Moderate valuation
4.3% revenue growth
Earnings declined 12.1%
Trading at 8.4x book value
Expensive relative to growth rate
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : ALGN
The strongest argument for ALGN centers on Debt/Equity, PEG Ratio, Price/Book. PEG of 0.80 suggests the stock is reasonably priced for its growth.
Bull Case : WST
The strongest argument for WST centers on Altman Z-Score, Debt/Equity, Operating Margin. Profitability is solid with margins at 17.0% and operating margin at 22.5%. Revenue growth of 13.8% demonstrates continued momentum.
Bear Case : ALGN
The primary concerns for ALGN are P/E Ratio, Revenue Growth, EPS Growth.
Bear Case : WST
The primary concerns for WST are Price/Book, PEG Ratio, P/E Ratio. A P/E of 43.5x leaves little room for execution misses.
Key Dynamics to Monitor
ALGN profiles as a value stock while WST is a mature play — different risk/reward profiles.
ALGN carries more volatility with a beta of 1.67 — expect wider price swings.
WST is growing revenue faster at 13.8% — sustainability is the question.
ALGN generates stronger free cash flow (162M), providing more financial flexibility.
Bottom Line
WST scores higher overall (61/100 vs 56/100), backed by strong 17.0% margins and 13.8% revenue growth. ALGN offers better value entry with a 32.9% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Align Technology Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Align Technology is a manufacturer of 3D digital scanners and the Invisalign clear aligners used in orthodontics. It is headquartered in San Jose, California.
West Pharmaceutical Services Inc
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
West Pharmaceutical Services, Inc. is a designer and manufacturer of injectable pharmaceutical packaging and delivery systems. The company is headquartered in Exton, Pennsylvania.
Compare with Other MEDICAL INSTRUMENTS & SUPPLIES Stocks
Want to dig deeper into these stocks?